CD8A and neoplasm: In melanoma experiments conducted on mice, they found that when combined with anti-PD-1 antibodies, the virus significantly increased CD8+ T cell numbers compared to using only the virus alone; furthermore, combining OV with ICIs significantly inhibited tumor development and prolonged survival time compared to using only the virus alone or ICIs alone.